ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Cash on Hand 2017–2025
ImmuCell Corporation annual cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- ImmuCell Corporation cash on hand as of December 31, 2025: 3.8M, a 1.29% increase year-over-year.
- ImmuCell Corporation cash on hand for 2025 were 3.8M, a 1.29% increase from 2024.
- ImmuCell Corporation cash on hand for 2024 were 3.8M, a 283.99% increase from 2023.
- ImmuCell Corporation cash on hand for 2023 were 978,741, a 83.10% decrease from 2022.
- ImmuCell Corporation cash on hand for 2022 were 5.8M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ImmuCell Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $4 |
| 2023 | $1 |
| 2022 | $6 |
| 2021 | $10 |
| 2020 | $7 |
| 2019 | $6 |
| 2018 | $3 |
| 2017 | $4 |
ImmuCell Corporation Cash on Hand — FAQ
ImmuCell Corporation (ICCC) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's cash on hand history?
The chart and table above show ImmuCell Corporation's cash on hand by year and by quarter, including the growth rate.